疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
, J/ p- g$ ^( ~% v
, J* ], F; X" Z2 p  X. qhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

( E) {- \0 j2 p! O; g: H, j0 `" ASECTION 1: General aspects of vaccination
7 J# w$ }8 _- B) Z1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
) q5 c1 Y6 r$ e9 @6 Vaccine additives and manufacturing residuals in the United States:
2 H: R  _7 s2 g& y3 x( blicensed vaccines 71
8 ]/ [: s: R% o" H2 J5 b& @8 J7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
5 ^" l8 [7 ~; `; ^) ^# {9 Adenovirus vaccines 113
& E) ~% k- k7 }: o, p10 Anthrax vaccines 127
11 Cholera vaccines 141
$ U7 s4 D; V4 Z, I" Q12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
! M: ]4 e' B/ w1 Z8 J% x  `) o% V9 {15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
  \; u3 Z1 B- \% V/ \1 ^* q' @17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
: I* J8 Y; k1 ~6 X21 Meningococcal vaccines 388
1 g/ s) O2 ?7 ?8 r22 Mumps vaccine 419
! n  S/ ?0 U9 m0 j: M23 Pertussis vaccines . 447
24 Plague vaccines 493
# V' j& L+ ?/ ~0 _% }0 k25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
  n# }3 \4 ]8 E; O9 O! v26 Pneumococcal polysaccharide vaccines 542
' e- G: }3 P. R' ?" p* f4 r. l27 Poliovirus vaccine-inactivated . 573
0 n# g& @# F5 L$ p; _28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
% `0 {+ q$ e( ]8 ~6 e6 L: E" b" F30 Rotavirus vaccines . 669
; {) j) c5 g8 w% A31 Rubella vaccine 688
( P1 F7 R; O3 \- B- _% c- c$ _1 Y9 {32 Smallpox and vaccinia 718
. {: Y* P7 a4 D0 c5 Y33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
! F: z/ _8 K$ u# @* n39 Zoster vaccine 969
3 P/ x/ y7 v8 r; E5 ~% `$ Y40 Combination vaccines 981
0 C4 q5 m4 F1 oSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
3 U6 d4 q- J" p4 f42 Therapeutic cancer vaccines 1018
. d; W3 w4 }- _; S* @, |43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
5 n& `4 J* s( e45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
+ c! ?: W; q  Y/ |. h  a, L47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
4 |6 Q$ l0 ]/ A! L* b* C! n50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
3 k  T5 D4 d, Y2 g+ \- z53 Malaria vaccines 1133
' e8 T7 e+ Z- ?54 Noninfectious disease vaccines 1138
" _# K/ T0 h8 L& T) w55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
' p3 t- G, l) d) ?8 b56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
6 F' X7 }2 \3 R# A0 ~60 Technologies for making new vaccines 1182
  m3 x8 R) l. {61 Alternative vaccine delivery methods 1200
- u* W) [) g2 O6 u! {62 The development of gene-based vectors for immunization 1232
& O& ^0 p0 J7 B/ o- v# `$ bSECTION 4: Vaccination of special groups
6 q$ |" U. _* z" }! U: P. m63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
: w2 K( C! P# P  f( \65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
4 _" b* U0 S( }3 OSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
0 ]+ \- V* v: e5 c$ g71 Community immunity 1395
9 z5 x' h6 D; y72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
: u" c) f* S9 z  ?74 Regulation of vaccines in Europe 1447
2 {; A" w& ~! m. T9 q) `- w75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508



9 b, ~! B5 E" z1 h% ~- E

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

( T$ }% f* R3 t, Z* C8 W/ hApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
8 z: W6 J: e" c
  F' ?# L; g4 O6 J" O8 Phttp://yun.baidu.com/share/link? ... 1&uk=3810996606
: n; c( F2 o5 h- X7 Z. U: E
( L; H7 ^7 I) E: P, j3 D* d$ V1 nSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
+ u2 H* ?3 |. d, E% _8 Q; d11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
- P* b  O. j% ?+ c, n8 I14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
- D7 X( G/ E7 U1 D  B5 x16 Human papillomavirus vaccines 235
6 m0 o8 J4 X, F- _% `8 h17 Inactivated influenza vaccines 257
7 K+ b- L# ]' }6 I, J18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
& r/ V# J& h0 i3 Y3 |* m6 Y3 f21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
) o) O, A8 G7 B: D3 f) ~24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
) I6 s2 n# E. ?% f2 q7 D27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
8 k7 F5 |1 q- F- S( C31 Rubella vaccine 688
1 J4 d, N# Z! C1 [32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
! J' y3 X3 o6 o1 J# ?* F% U34 Tick-borne encephalitis virus vaccines 773
* \9 J5 O$ w  S4 M1 e' Z; h35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
; \& s, z- |; h/ i37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
, I( z/ G& d0 g2 T41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
% L5 q( u2 O: \2 R: d* S: L, p! `43 Cytomegalovirus vaccines 1032
1 K4 `+ L. P7 w- [4 Z) O1 Y44 Dengue vaccines 1042
( n# i; q) v. n$ ]& k8 A5 g3 n45 Diarrhea caused by bacteria 1052
5 O1 z/ E# _% U" c/ a46 Ebola vaccine 1060
$ l, j0 I9 V! ^& o! |/ O( J47 Epstein-Barr virus vaccines 1068
# C& j* Q3 e6 ?1 G7 v3 i48 Hepatitis C vaccines 1074
1 R9 D) y7 G5 s4 ~5 i; ?. k( T5 Z49 Hepatitis E vaccines 1085
; n8 F' @) T+ Q50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
! W( N$ _! a& A52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
! b. z) [6 m# O9 z54 Noninfectious disease vaccines 1138
; v0 _% K1 l- ~7 ~4 V0 G: i55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
. S( B8 D" X3 ~% S. U! I59 Streptococcus group B vaccines 1176
  ~( q. g3 u/ u' Q60 Technologies for making new vaccines 1182
9 c+ p" T& B1 ^  s8 m. J61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
8 k1 j4 X: |* h1 tSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
7 ~  [6 n' M9 {) a" C64 Vaccination of human immunodeficiency virus-infected persons 1257
, z# x# c4 n% ?65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
; @: z4 D4 S2 r67 Immunization in the United States 1310
68 Immunization in Europe . 1334
$ ]+ e% P2 k# L! V69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
/ u0 S6 ?0 j) V72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
4 n) U/ R6 T/ ~% n) G. s* `74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
7 Y- V: u$ s5 A/ e0 }. t

7 x7 s5 I" ^) T6 M) Y7 i

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
% J$ H' r0 e0 }1 K+ I5 I$ gPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
" `; Y0 M* G  \2 RISBN-10: 1455700908
Size: 52.3mb (original pdf)

! {" X+ i( Z1 v, r8 o. Q/ N2 o2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
; N! G) v) i( S; A1 k+ j' F
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
9 D  M/ P5 j  }( O1 p& {5 t) Y: MPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
0 Z' n; G& C* u6 wMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
, G( j- Z3 A) n) o; U9 z# e" `Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
' R- f5 A0 m) R
# t+ V. ]- {3 E( Y) ~Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96